The behavioural effects of systemically administered kainic acid: A pharmacological analysis

Systemic injection of kainic acid (KA), a powerful neuroexcitant and structural analogue of glutamate, induced a complex behaviour in the rat characterized by early “wet-dog-shakes” (WDS and delayed convulsions. 1) The WDS syndrome was antagonized by serotonin blockers (mianserin and cyproheptadine) and by GABAmimetic agents, which decrease serotonergic transmission; in contrast, WDS were potentiated by compounds which enhance serotonin-mediated events (fluoxetine, fenfluramine, imipramine and tranylcypromine) as well as by blockade of GABA receptors (bicuculline). In addition, WDS were antagonized by haloperidol (which possesses some anti-serotonin properties) whereas KA potentiated haloperidol-induced catalepsy, an effect which was blocked by cyproheptadine. This suggests that KA induces WDS and potentiates catalepsy via an increase in serotoninergic function. 2) KA induced convulsions were antagonized by GABAmimetic agents, in agreement with their broad anticonvulsant spectrum; in contrast, mianserine and cyproheptadine did not affect or even potentiated seizures. Thus KA seizures respond differently to pharmacological treatment than do WDS, and may me related to the nwuro-excitatory action of KA.